Biblio

Export 417 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Keyword is S  [Clear All Filters]
Journal Article
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
G. - H. Lee, Jang, B., Choi, H. - S., Kim, H. - J., Park, J. - H., Jeon, Y. - C., Carp, R. I., Kim, Y. - S., and Choi, E. - K., “Upregulation of Connexin 43 Expression Via C-Jun N-Terminal Kinase Signaling in Prion Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1005-19, 2016.
Z. Shi, Zhu, Y., Wang, M., Wu, Y., Cao, J., Li, C., Xie, Z., and Shen, Y., “The Utilization of Retinal Nerve Fiber Layer Thickness to Predict Cognitive Deterioration.”, J Alzheimers Dis, vol. 49, no. 2, pp. 399-405, 2016.
X. Feng, Zhou, A., Liu, Z., Li, F., Wei, C., Zhang, G., and Jia, J., “Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1611-1618, 2018.
X. Feng, Zhou, A., Liu, Z., Li, F., Wei, C., Zhang, G., and Jia, J., “Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1611-1618, 2018.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
S. Lynn Lim, Gao, Q., Nyunt, M. Shwe Zin, Gong, L., Lunaria, J. B., Lim, M. Li, Ling, A., Lam, C. Su- Ping, Richards, A. Mark, Ling, L. Hsi, and Ng, T. Pin, “Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies.”, J Alzheimers Dis, vol. 50, no. 1, pp. 27-40, 2016.
A. Pilotto, Turrone, R., Liepelt-Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., Cosseddu, M., Cottini, E., Berg, D., and Padovani, A., “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.”, Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., “VEGFR1 and VEGFR2 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., “Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
I. W. M. van Uden, van der Holst, H. M., Tuladhar, A. M., van Norden, A. G. W., de Laat, K. F., Rutten-Jacobs, L. C. A., Norris, D. G., Claassen, J. A. H. R., van Dijk, E. J., Kessels, R. P. C., and de Leeuw, F. - E., “White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 863-73, 2016.
C. Huang, Kritikos, M., Clouston, S. A. P., Deri, Y., Serrano-Sosa, M., Bangiyev, L., Santiago-Michels, S., Gandy, S., Sano, M., Bromet, E. J., and Luft, B. J., “White Matter Connectivity in Incident Mild Cognitive Impairment: A Diffusion Spectrum Imaging Study of World Trade Center Responders at Midlife.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1209-1219, 2021.

Pages